医院丙型肝炎感染防控管理的探索与实践

doi:10.3969/j.issn.1672-5069.2014.05.030

摘要/Abstract

摘要： 本文旨在探讨医院开展丙型肝炎院内感染防控管理的必要性和可行性,以及如何采取有效的干预策略,建立相对规范、完善的管理体系,持续改进丙型肝炎院内感染的防控效果。我院通过加强宣传培训,引进联络员制度,充分做好患者知情同意等工作,使医务人员及患者提高了对丙型肝炎的认识和重视程度,各相关科室之间形成较为顺畅的联系与协作关系,使丙型肝炎院内感染防控取得显著成效。分析加强管理前2011年与加强管理后2012年比,全院非感染科抗HCV检测例数占全院手术例数的比例、非感染科抗-HCV阳性人群HCV RNA检测率分别增长了5.87%和28.4%。可见,医院有能力也有必要,通过采取有效的干预策略,加强丙型肝炎院内防控管理,保护医患人员的安全与权益。

关键词: 丙型肝炎, 院内感染, 防控, 管理

Abstract: This review aims to discuss the necessity and feasibility of preventing and controlling hepatitis C virus （HCV） infection in hospitals,and how to take effective strategies of intervention,establish a relatively standard and complete management system,and improve the effectiveness of management continually. The Third Affiliated Hospital of Sun Yat-Sen University enhanced the publicity and training of staffs,introduced the liaison system,and ensured patients’ informed consent. With these efforts,the medical personnel and the patients have increased awareness of HCV infection and paid more attention to it,and the relevant divisions have achieved cross-sectional cooperation and worked well. The percentage of anti-HCV screening to surgical cases and the percentage of HCV RNA screening in cases with anti-HCV positive in 2012 raised by 5.87% and 28.4%,respectively,as compared to in 2011. It is obvious that hospitals are able and necessary to strengthen management of preventing and controlling the HCV infection with effective measures to protect the safety and rights of patients’ and medical personnel’.

Key words: Hepatitis C, Nosocomial infection, Prevention and contro, Management

姚麟, 连晓鹏综述, 杨扬审校. 医院丙型肝炎感染防控管理的探索与实践[J]. 实用肝脏病杂志, 2014, 17(5): 550-552.

Yao Lin, Lian Xiaopeng, Yang Yang. Prevention and control of nosocomial hepatitis C virus infection in our hospital[J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2014, 17(5): 550-552.

参考文献

[1] 刘童童,肖瓅,李雨波,等. 不同人群丙型肝炎知识及行为和宣传资料需求调查. 中国艾滋病性病,2010,16（3）:273-276.
[2] 苏华瑜,梁光,王丽荣,等.2008年湛江市吸毒、劳改等重点人群丙型肝炎检测结果分析. 华南预防医学,2009,35（4）:26-28.
[3] 王英,王锐,赵亮,等.临淄区近10年丙型肝炎流行特征和控制策略. 中医学动物防治,2009,25（8）:580-581.
[4] 徐斌,黄夏萍,唐莉,等.南宁市2004~2007年病毒性肝炎流行特点. 热带医学杂志,2008,8（9）:952-954.
[5] 李晓娟,颜伟,周平,等.丙型病毒感染并发2型糖尿病的临床研究. 西南国防医药,2009,19（8）:777-779.
[6] 中国疾病预防控制中心.全国历年各月份法定传染病疫情.http://www.chinacdc.cn/tjsj/fdcrbbg/. 2005~2012年.
[7] 林潮双,赵志新,张晓红,等.广州市2005~2008年丙型肝炎疫情分析. 中华肝脏病杂志,2010,18（1）:56-57.
[8] U.S. Centers for Disease Control and Prevention. Hepatitis C FAQs for health professionals. http://www.cdc.gov/hepatitis/HCV/HCVfaq.htm. May 28, 2013.
[9] 高志良,张晓红. 重视丙型肝炎的治疗研究.实用肝脏病杂志,2012,15（5）:377-378.
[10] 谢尧,李明慧.慢性丙型肝炎标准抗病毒治疗的新时代. 实用肝脏病杂志,2012,15（5）:384-386.
[11] Yu ML,Dai CY,Huang JF,et al. Rapid virological response and treatment duration for chronic hepatitis C genotype 1 patients:a randomized trial.Hepatology,2008,47（6）:1884-1893.
[12] Swain MG,Lai MY,Shiffman ML,et al. A sustained virologic response is durable in patients with chronic hepatitis C treated with peginterferon alfa-2a and ribavirin.Gastroenterology,2010,139（5）:1593-1601.
[13] Snoeck E,Wade JR,Duff F,et al. Predicting sustained virological response and anaemia in chronic hepatitis C patients treated with peginterferon alfa-2a （40KD） plus ribavirin.Br J Clin Pharmacol,2006, 62（2）:699-709.
[14] Poynard T,Ratziu V,Charlotte F,et al. Rates and risk factors of liver fibrosis progression in patients with chronic hepatitis C. J Hepatol,2001,34（5）:730-739.
[15] 施小明,马家奇,王丽萍,等. 2005年全国医疗机构法定传染病漏报情况调查分析. 疾病监测,2006,21（9）:493-496.
[16] 中华预防医学会医院感染控制分会.中国丙型病毒性肝炎医院感染防控指南. 中国肝脏病杂志,2012,4（3）:28-33.
[17] W.H.O. Hepatitis C:global prevalence. Wkly Epidemiol Rec, 1997,72（46）:341-344.
[18] 中华医学会肝病学分会,中华医学会传染病与寄生虫病学分会.丙型肝炎防治指南. 中华肝脏病杂志,2004,12（4）:194-198.
[19] 亚太地区肝病研究协会丙型肝炎协助组.亚太区肝病年会丙型肝炎诊治专家共识. 中华实验和临床感染病杂志,2007,1（1）:88-94.
[20] 曹红.丙型肝炎的诊断. 实用肝脏病杂志,2012,15（5）:382-383.
[21] 于笑难,付炜昕,蒋莉,等.外科手术患者丙型肝炎病毒感染调查. 中国公共卫生,2002,18（2）:199-200.
[22] 唐敏云.3660例丙型肝炎抗体检测结果分析.中国卫生检验杂志,2007,17（11）:2102,2113.
[23] 阴燕舞.手术患者术前丙型肝炎抗体检测调查分析.青海医药杂志,2009,39（6）:70.
[24] 陈远林,秦立新,张仁生,等. 住院患者血液传染性相关指标检测的意义. 中华医院感染学杂志,2007,17（4）:388-390.
[25] 向尹,郭勇.常规体检检测丙型肝炎病毒抗体的临床意义.检验医学与临床,2007,4（8）:711.
[26] 李淑霞,孙丽波,刘秀英.常规体检人群丙型肝炎抗体检测的回顾性分析. 宁夏医学杂志,2008,30（12）:1156-1157.
[27] Karmochkine M,Carrat F,Dos Santos O,et al. A case-control study of risk factors for hepatitis C infection in patients with unexplained routes of infection.J Viral Hepat,2006,13（11）:775-782.
[28] 胡晓武,丁必芝.丙型肝炎流行病学及临床特征调查分析. 实用肝脏病杂志,2010,13（3）:188-189,192.
[29] 齐俊英,谢复东,郭林生,等. 维持性血液透析及肾移植患者乙型及丙型肝炎病毒感染调查.中华医学感染学杂志,2003,13（9）:806-807.
[30] 李杰,陈杰,庄辉.丙型肝炎的流行病学.实用肝脏病杂志,2012,15（5）:379-381.
[31] 喜斌,刘伟,孟春梅. 医护人员HBV和HCV院内感染. 哈尔滨医科大学学报,2001,35（4）:314.
[32] Deterding K,Wiegand J,Gruner N,et al. The german hep-net acute hepatitis C cohort:impact of viral and host factors on the initial presentation of acute hepatitis C virus infection. Z Gastroenterol,2009,47（6）:531-540.
[33] 唐荣智,钱水娟,王珍.输血后丙型肝炎法律责任探析. 北京政法职业学院学报,2006,（2）:1-7.